Jpmorgan Chase & CO Edgewise Therapeutics, Inc. Transaction History

Jpmorgan Chase & CO

$1.22 Trillion
Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 158,506 shares of EWTX stock, worth $5.06 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

158,506

Previous 64,359 146.28%

Holding current value

$5.06 Million

Previous $1.16 Million 264.97%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$15.88 - $29.5 $1.5 Million - $2.78 Million	94,147 Added 146.28%	158,506 $4.23 Million
Q2 2024 Aug 12, 2024	BUY	$15.08 - $21.23 $324,612 - $456,996	21,526 Added 50.26%	64,359 $1.16 Million
Q1 2024 May 10, 2024	BUY	$9.25 - $19.97 $25,622 - $55,316	2,770 Added 6.91%	42,833 $781,000
Q4 2023 Feb 12, 2024	SELL	$5.51 - $12.1 $2,429 - $5,336	-441 Reduced 1.09%	40,063 $438,000
Q3 2023 Nov 14, 2023	BUY	$5.73 - $7.69 $28,225 - $37,880	4,926 Added 13.85%	40,504 $232,000
Q2 2023 Aug 11, 2023	BUY	$5.71 - $10.29 $23,970 - $43,197	4,198 Added 13.38%	35,578 $275,000
Q1 2023 May 18, 2023	BUY	$6.66 - $11.33 $193,379 - $328,977	29,036 Added 1238.74%	31,380 $209,000
Q1 2023 May 11, 2023	SELL	$6.66 - $11.33 $146,340 - $248,954	-21,973 Reduced 90.36%	2,344 $15,000
Q4 2022 Feb 13, 2023	BUY	$7.58 - $11.08 $34,261 - $50,081	4,520 Added 22.83%	24,317 $217,000
Q3 2022 Nov 14, 2022	SELL	$8.08 - $13.58 $10,600 - $17,816	-1,312 Reduced 6.22%	19,797 $195,000
Q2 2022 Aug 11, 2022	SELL	$5.67 - $9.87 $34,343 - $59,782	-6,057 Reduced 22.3%	21,109 $168,000
Q1 2022 May 11, 2022	BUY	$9.1 - $18.97 $46,919 - $97,809	5,156 Added 23.43%	27,166 $263,000
Q4 2021 Feb 10, 2022	BUY	$14.41 - $22.41 $209,391 - $325,639	14,531 Added 194.29%	22,010 $337,000
Q3 2021 Nov 12, 2021	BUY	$14.11 - $24.1 $105,528 - $180,243	7,479 New	7,479 $124,000

Others Institutions Holding EWTX

# of Institutions

191

Shares Held

100M

Call Options Held

2.17M

Put Options Held

410K

View Full List

About Edgewise Therapeutics, Inc.

Ticker EWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 63,171,700
Market Cap $2.02B
Description
Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...

More about EWTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Edgewise Therapeutics, Inc. Transaction History